genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Biogen
Cancer
StockWatch: Biogen’s New CEO Takes Slow Approach to New Cost Cuts
GEN Edge
Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines
Cancer
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Bioprocessing
Challenges in Biologics R&D
GEN Edge
StockWatch: Biogen Shares Rebound as Alzheimer’s Drug Aces Phase III Trial
Drug Discovery
Longer-Term Use of Investigational Drug Stabilizes ALS Symptoms
GEN Edge
Scribe Pursues CRISPR Therapies with Expanded Biogen Collaboration
Cancer
StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks
A-Lists
Top 25 Biotech Companies of 2022
Cancer
StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data
1
2
3
4
...
21
Page 3 of 21
Scroll Up
Scroll Up
